Related Experiment Video
Updated: Aug 29, 2025

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Published on: August 17, 2011
Calcium Channel Blocker Toxicity: A Practical Approach.
Omar A Alshaya1,2,3, Arwa Alhamed3,4, Sara Althewaibi1
1Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Calcium channel blocker (CCB) toxicity is common, especially in children, and can cause severe outcomes. This guide details management strategies like IV fluids, calcium, and high insulin euglycemia therapy (HIET) for CCB overdose.
Area of Science:
- Pharmacology
- Toxicology
- Clinical Medicine
Background:
- Calcium channel blockers (CCBs) are frequently prescribed for adults and children.
- CCB toxicity is a significant concern due to widespread use, leading to adverse outcomes, particularly in pediatric populations.
- Severe toxicity can manifest as bradycardia, hypotension, hyperglycemia, and renal issues, with dihydropyridines potentially causing reflex tachycardia.
Purpose of the Study:
- To summarize evidence-based management strategies for calcium channel blocker toxicity.
- To provide a practical clinical guide for managing CCB overdose in diverse patient groups.
- To highlight the importance of initial assessment in determining effective treatment approaches.
Main Methods:
- Review of existing literature on CCB toxicity and its management.
- Analysis of different therapeutic interventions, including fluid resuscitation, calcium administration, high insulin euglycemia therapy (HIET), and vasopressors.
- Focus on precise dosing and close monitoring protocols for various patient populations.
Main Results:
- Effective management strategies for CCB toxicity include IV fluids, calcium salts, HIET, and vasopressors.
- Differentiating between dihydropyridine and nondihydropyridine toxicity is crucial for tailored treatment.
- Close patient monitoring and precise dosing are essential for successful outcomes.
Conclusions:
- CCB toxicity requires prompt and accurate clinical evaluation and management.
- A multi-faceted approach involving specific antidotes and supportive care is necessary.
- This guide aims to equip clinicians with the knowledge to effectively manage CCB toxicity.
More Related Videos
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
11:32Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Heart Failure Drugs: Inotropic Agents